Both flow cytometric and pathological analysis revealed that the silencing of glioma-derived galectin-1 significantly decreased the amount of brain-infiltrating macrophages and myeloid-derived suppressor cells (MDSCs) in tumor-bearing mice. The gene discussed is LGALS1; the disease is central nervous system cancer.